Home / Inspections / 1060670

FDA Inspection 1060670 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 3004829714

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on June 20, 2018 in Philadelphia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Philadelphia, PA (United States)

Facility

Other inspections at this facility

  • 1277181 (NAI Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1175133 (VAI Fri Jul 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940375 (VAI Wed May 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846805 (VAI Wed May 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 747381 (VAI Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources